These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12708938

  • 1. An interventional program to improve antibiotic use.
    Feucht CL, Rice LB.
    Ann Pharmacother; 2003 May; 37(5):646-51. PubMed ID: 12708938
    [Abstract] [Full Text] [Related]

  • 2. An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse.
    Wong-Beringer A, Nguyen LH, Lee M, Shriner KA, Pallares J.
    Pharmacotherapy; 2009 Jun; 29(6):736-43. PubMed ID: 19476424
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.
    Thomas AR, Cieslak PR, Strausbaugh LJ, Fleming DW.
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):683-8. PubMed ID: 12452297
    [Abstract] [Full Text] [Related]

  • 4. Improving the appropriateness of vancomycin use by sequential interventions.
    Lipsky BA, Baker CA, McDonald LL, Suzuki NT.
    Am J Infect Control; 1999 Apr; 27(2):84-91. PubMed ID: 10196484
    [Abstract] [Full Text] [Related]

  • 5. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ, Liu HY, Lin YC, Sun KL, Chun CL, Hsueh PR.
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin use in a university medical center: effect of a vancomycin continuation form.
    Evans ME, Millheim ET, Rapp RP.
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):417-20. PubMed ID: 10395144
    [Abstract] [Full Text] [Related]

  • 7. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.
    Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM.
    J Antimicrob Chemother; 2012 Apr; 67(4):1010-5. PubMed ID: 22240401
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff.
    Richardson LP, Wiseman SW, Malani PN, Lyons MJ, Kauffman CA.
    Microb Drug Resist; 2000 Apr; 6(4):327-30. PubMed ID: 11272262
    [Abstract] [Full Text] [Related]

  • 9. Intervention of inappropriate antibiotic use at a university teaching hospital.
    Udomthavornsuk B, Tatsanavivat P, Patjanasoontorn B, Khomthong R, Bhuripanyo K, Saengnipanthkul S, Lumbiganon P, Wiengnond S, Boonma P, Vongsangnak V.
    J Med Assoc Thai; 1991 Oct; 74(10):429-36. PubMed ID: 1797952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective vancomycin audit in Auckland healthcare hospitals.
    Drinkovic D, Taylor SL, Pottumarthy S, Morris AJ.
    N Z Med J; 1999 Sep 10; 112(1095):336-9. PubMed ID: 10553935
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
    Anglim AM, Klym B, Byers KE, Scheld WM, Farr BM.
    Arch Intern Med; 1997 May 26; 157(10):1132-6. PubMed ID: 9164379
    [Abstract] [Full Text] [Related]

  • 14. Impact of an Antimicrobial Stewardship Program on Antibiotic Use at a Nonfreestanding Children's Hospital.
    Turner RB, Valcarlos E, Loeffler AM, Gilbert M, Chan D.
    J Pediatric Infect Dis Soc; 2017 Sep 01; 6(3):e36-e40. PubMed ID: 28903514
    [Abstract] [Full Text] [Related]

  • 15. [Relevance of fluoroquinolone use in Nancy's hospital. Results of the first turn].
    Desmots E, Demore B, Doco-Lecompte T, Burty C, Rabaud C, May T.
    Pathol Biol (Paris); 2011 Apr 01; 59(2):122-6. PubMed ID: 20570055
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluoroquinolone prescriptions in a teaching hospital: a prospective audit.
    Pulcini C, Mondain V, Lieutier F, Mousnier A, Roger PM, Dellamonica P.
    Scand J Infect Dis; 2007 Apr 01; 39(11-12):1013-7. PubMed ID: 17852936
    [Abstract] [Full Text] [Related]

  • 18. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.
    Levy ER, Swami S, Dubois SG, Wendt R, Banerjee R.
    Infect Control Hosp Epidemiol; 2012 Apr 01; 33(4):346-53. PubMed ID: 22418629
    [Abstract] [Full Text] [Related]

  • 19. Vancomycin in Oregon: who's using it and why.
    Cieslak PR, Strausbaugh LJ, Fleming DW, Ling JM.
    Infect Control Hosp Epidemiol; 1999 Aug 01; 20(8):557-60. PubMed ID: 10466557
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.